Ebola virus disease (EVD) is a severe infectious disease which caused an epidemic in West Africa in 2013-2015, and has resulted in at least 10,000 confirmed deaths. Early diagnosis of … Continue Reading Cell-free microRNA identified as biomarker for early diagnosis of Ebola.
In recent years, Ebola outbreaks have increased in frequency, duration, and geographical spread, underscoring the need for pre- and post-exposure treatments. Antibodies targeting the Ebola virus surface glycoprotein, the viral structure … Continue Reading Previously unknown ebola-fighting antibodies identified in outbreak survivor’s blood.
A collaborative team from The University of Texas and the National Institutes of Health have developed an inhalable vaccine that successfully protects primates against Ebola in simian trials. The team … Continue Reading First ever inhalable ebola vaccine is successful in simian trials.
Live Ebola virus can persist within the eyes for months after a patient recovers from acute Ebola viral disease (EVD), according to a case report from researchers at Emory University. … Continue Reading Ebola virus can persist for months within survivors’ eyes.
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check … Continue Reading New strategy attacks the ebola virus at a RNA level and stops viral replication.
In the ongoing Ebola outbreak in West Africa, whose death toll is approaching 10,000, little information has been available about how the human immune response unfolds after infection. Now, researchers … Continue Reading First look at hospitalized Ebola survivors’ immune cells finds no immunosuppression.
Researchers from the LSU Health New Orleans School of Medicine have identified the fragment of the Ebola virus protein that is toxic to cells and may contribute to infection and … Continue Reading Breakthrough as scientists identify, map and model the toxic fragment of the Ebola virus.
The outbreak of the Ebola virus disease occurring in West Africa may have originated from contact between humans and virus-infected bats, suggests a study led by researchers from the Robert … Continue Reading Researchers investigate animal host for the origin of the West African Ebola epidemic.
A great year for healthinnovations with exciting discoveries, verifications, validations and breakthroughs. The big disease areas are still cancer, heart disease, diabetes and Alzheimer’s, however, it’s the methodology of detection, … Continue Reading The Top Ten Healthinnovations of 2014.
The World Health Organization (WHO) has stated in a release that human sperm can carry the Ebola virus for at least 82 days, urging men recovering from the disease to use condoms … Continue Reading Four studies find Ebola virus in semen of men who have recovered from the disease.
A new United States Army contracted study has found it is possible to distinguish between different hemorrhagic fevers, including Marburg (Ebola cousin) and Lassa before the person becomes symptomatic. The embargoed … Continue Reading RNA test diagnoses Lassa and Marburg hemorrhagic viruses before symptoms show.
The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in … Continue Reading Researchers to test whether Ebola survivors’ blood can provide new treatment.
A family of proteins that promotes virus entry into cells also has the ability to block the release of HIV and other viruses, University of Missouri researchers have found. This … Continue Reading Researchers discover protein’s ability to inhibit HIV release.
One of the human body’s first responses to a viral infection is to make and release signalling proteins called interferons, which amplify the immune system response to viruses. Over time, … Continue Reading Ebola protein blocks early step in body’s counterattack on virus.